menu ☰
menu ˟

More research needed to realize true benefit of PARP inhibitors in breast cancer

08 Nov 2018
NEW YORK — The effectiveness of PARP inhibitors demonstrate a proof of principle that targeting DNA repair pathways can be a productive treatment strategy, but more research is necessary to extend their benefit, according to a presenter at Chemothe...

Click here to view the full article which appeared in Hematology Oncology

IPH Logo